跳至主要内容
临床试验/JPRN-UMIN000039076
JPRN-UMIN000039076已完成未知

PARP Inhibitors-induced nausea and vomiting in patients with gynecologic cancer: a prospective, observational, multicenter study. - PARP Inhibitors-induced nausea and vomiting in patients with gynecologic cancer: a prospective, observational, multicenter study.

Gifu University0 个研究点目标入组 234 人开始时间: 2020年1月31日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
234

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1.Patients with a reduction in the initial dose of olaparib and niraparib 2.Patients who need antiemetics at the enrollment. 3.Patients who start taking opioids within 48 hours prior to enrollment 4.Patients with ascites effusion requiring paracentesis 5.Patients with symptomatic brain metastases and cancerous meningitis 6.Patients who have gastrointestinal obstruction 7.Patients who received abdominal or pelvic irradiation within 6 days prior to enrollment 8.Patients who use any drug with antiemetic activity, including NK1RA, 5-HT3RA, corticosteroids, dopamine receptor antagonists, phenothiazine tranquilizers, SSRI, SNRI, SDA, MARTA within 6 days prior to enrollment 9.Other patients who are judged to be inappropriate for the study by the investigator

研究者

相似试验